Bacteria-derived vesicles and uses thereof
AssigneeExocure Sweden AB
InventorsKyong-su Park, Rossella Crescitelli, Jan Lötvall
Life of this patent
Estimating the term…
Loading patent…
AssigneeExocure Sweden AB
InventorsKyong-su Park, Rossella Crescitelli, Jan Lötvall
Estimating the term…
Non-naturally occurring vesicles derived from bacteria, e.g., pathogenic bacteria, methods for making the vesicles, and methods for using compositions of these vesicles are disclosed. Methods of using the vesicles include prevention and/or treatment of bacterial infections. Also provided herein are compositions that include vesicles derived front bacteria and tumor vesicles, methods for making the tumor vesicles, and methods for using the compositions of bacterial vesicles and tumor vesicles. Methods of using the compositions of bacterial vesicles and tumor vesicles include treatment of cancer in a subject. Tumor vesicles may be derived from cancer cells present in the subject to be treated or from a cancer cell line expressing at least one neoantigen. The neoantigen may be specific to the subject and may have been identified by sequencing of the cancer cells from the subject. The neoantigen may be a neoantigen known to be commonly expressed in a particular type of cancer.
A composition comprising non-naturally occurring artificial outer membrane vesicles (aOMVs) generated from a gram-negative bacterium,
A method for generating non-naturally occurring artificial outer membrane vesicles (aOMVs) from a gram-negative bacterium, the method comprising:
A method for generating non-naturally occurring artificial outer membrane vesicles (aOMVs) from a gram-negative bacterium, the method comprising:
Dependencies are inferred from the claim text.